newdrugapprovals.org
Genzyme’s multiple sclerosis treatment approved by European Commission
Alemtuzumab Sanofi and its subsidiary Genzyme have been given marketing approval by the European Commission for Lemtrada (alemtuzumab), a treatment for multiple sclerosis. read all at click on tit…